The outsourcing of clinical trials to Latin America by the transnational innovative pharmaceutical industry began about twenty years ago. Using archival information and field work in Argentina, Brazil, Costa Rica, Mexico and Peru, the authors discuss the regulatory contexts and the ethical dimensions of human experimentation in the region. More than 80% of all clinical trials in the region take place in these countries, and the European Medicines Agency has defined them as priority countries in Latin America. The authors raise questions about the quality of data obtained from the trials and the violation of human rights during their implementation. Their findings are presented in this volume, the first in-depth analysis of clinical trials in the region.

Human information and communication technology (ICT) implants have developed for many years in a medical context. Such applications have become increasingly advanced, in some cases modifying fundamental brain function. Today, comparatively low-tech implants are being increasingly employed in non-therapeutic contexts, with applications ranging from the use of ICT implants for VIP entry into nightclubs, automated payments for goods, access to secure facilities and for those with a high risk of being kidnapped. Commercialisation and growing potential of human ICT implants have generated debate over the ethical, legal and social aspects of the technology, its products and application. Despite stakeholders calling for greater policy and legal certainty within this area, gaps have already begun to emerge between the commercial reality of human ICT implants and the current legal frameworks designed to regulate these products. This book focuses on the latest technological developments and on the legal, social and ethical implications of the use and further application of these technologies.

The research field of biobanks and tissue research is highly promising. Many projects around the globe are involved in the collection of human tissue and health data for research purposes. These initiatives are driven by the perspective of decisive breakthroughs in the knowledge of the genetic pathways involved in widespread diseases. However, there are considerable ethical and legal challenges to be considered as well. These challenges encompass the use of body material for research purposes, the misuse of genetic and other health data by third parties, trust in science and medicine, concerns regarding privacy, use of genetic data for forensic applications by the state and the police, and regulatory issues. This volume is divided into three parts: the inclusion of the public, the rights of donors and patients, examples and recommendations for the future of tissue research. It presents a comprehensive overview of the most important topics in the field by renowned scholars in medical ethics and biolaw.

This book addresses the debate usually tagged as being about 'markets in human body parts' which is antagonistically divided into pro-market and anti-market positions. The author provides a set of propositions about how to approach this and shows a way out of the concrete impasse of it. Assumptions about markets and bodies that characterize this debate are analyzed and described while the author argues that these assumptions are in fact constitutive for exchanges of human bodily material - but in unacknowledged ways. It is concluded that what we need is a different analytical approach to better understand the mechanisms at play when organizations exchange organs, tissues and cells for use in transplantation and fertility medicine.

This book provides a perspective on the concepts placebo and placebo effects, which has been missing so far: a detailed analysis of the history of the terms, their current use, suggested alternatives and the implications of the conceptual confusion. Everybody knows something about placebos and placebo effects. If, however, people are asked to define the concepts, the spectrum becomes wide. Does 'placebo' refer to an inert treatment or does it cover all elements of the patient-physician-interaction except for pharmacological or other physiological mechanisms? Furthermore, if, by definition, a placebo has no effect, what sense does it make to talk about a 'placebo effect'? Even in scientific literature the concepts 'placebo' and 'placebo effect' are used in many senses and often in a confusing way. While this book discusses many issues which keep puzzling physicians, it also covers the historical developments of the concepts of placebo and placebo effect as well as the conceptual confusion in the definitions. This book is intended for physicians, philosophers, psychologists and any other people interested in placebos, placebo effects and the physician-patient relationship.

Every day, newspapers and television news programs present stories on the latest controversies over healthcare and medical advances, but they do not have the space to provide detailed background on the issues. Websites and weblogs provide information from activists and partisans intent on presenting their side of a story. But where can students - or even ordinary citizens - go to obtain unbiased, detailed background on the medical issues affecting their daily lives? This volume in the Health and Medical Issues Today series provides readers and researchers a balanced, in-depth introduction to the medical, scientific, legal, and cultural issues surrounding organ tranplants and its import in today's world of healthcare. Organ Transplantation is organized to provide readers with easy access to the information they need: BLSection 1 provides overview chapters on the background information needed to intelligently understand the issues and controversies surrounding organ transplants, such as how organs are procured and who determines who gets an organ. BLSection 2 offers capsule examinations of the contemporary issues and debates that provoke the most heated disagreements and misunderstandings, such as controversies over who deserves to get an organ, and the concerns over xenotransplantation BLSection 3 includes reference material on organ transplantation, including primary source documents from important players in the debates, a timeline of important events, and an annotated bibliography of useful print and electronic resources. This volume in the Health and Medicine Today series provides everything a student requires to understand the issues involved in organ transplantation and provides aspringboard for further research into the issue

The increase in new medical technology and experimental treatments has made the study of medical ethics essential for practitioners on all levels. This book brings together experts in the fields of pediatric hemotology/oncology, ethics, and law to examine legal and ethical issues surrounding the treatment of children with cancer or blood disease. The contributors present thoughtful discussions of ethical considerations of such practices as bone marrow transplantation, caring for hemophiliacs, preventing sickle cell disease, informing patients of treatment side effects, the statistical design of clinical trials, and the activities of the Institutional Review Board.

Contemporary Dutch policy and legislation facilitate the use of high quality, accessible and affordable assisted reproductive technologies (ARTs) to all citizens in need of them, while at the same time setting some strict boundaries on their use in daily clinical practices. Through the ethnographic study of a single clinic in this national context, Patient-Centred IVF examines how this particular form of medicine, aiming to empower its patients, co-shapes the experiences, views and decisions of those using these technologies. Gerrits contends that to understand the use of reproductive technologies in practice and the complexity of processes of medicalization, we need to go beyond 'easy assumptions' about the hegemony of biomedicine and the expected impact of patient-centredness.

The contributions to this volume grew out of papers presented at an international conference Individual, Community & Society: Bioethics in the Third Millennium, held in Hong Kong, Special Administrative Region of the People's Republic of China, between 25-28 May 1999. The conference was organized by the Centre for Comparative Public Management and Social Policy, and Ethics in Contemporary China Research Group, in the Faculty of Humanities and Social Sciences at the City University of Hong Kong. The conference brought together scholars from east and west to investigate the challenges to caring and to traditional moral authorities that would confront bioethics in the third millennium. They explored the implications of moral loss and moral diversity in post-traditional and post-modern societies, and how these would shape the character of medical care and bioethics discourse in the new era. A proceedings volume under the same title of Individual, Community & Society: Bioethics in the Third Millennium, was published in May 1999 for the conference meeting.

Improving human characteristics goes beyond compensating for an impairment. This book explores the rich and complex relationship between enhancement and impairment, showing that the study of disability offers new ways of thinking about the social and ethical implications of improving the human condition.

Increasingly digital technologies are used in healthcare. This book explores eight digital health technologies, situated the context of a life span, from high-throughput genomic sequencing technologies and do-it-yourself (DIY) insulin delivery for diabetes management in paediatrics, to the use of robotic care assistants for older adults and digital advance care decisions. A scene-setting case scenario at the start of each chapter describes the digital technology and identifies the sometimes competing interests of the key stakeholders. Broad themes of resource allocation, access to technologies, informed consent, privacy of health data and ethical concerns are considered in context, alongside analysis of legal duties owed by healthcare professionals to act in their patients' best interests. This book addresses legal and ethical issues arising from the use of emerging digital health technologies and is of interest to academics, clinicians and regulators and anyone interested in the development of health technologies and the challenges they may present. It focusses on the Australian legal framework, with some comparison to other jurisdictions.

PERSONHOOD AND HEALTH CARE This book arose as a result of a pre-conference devoted to the topic held June 28, 1999 in Paris, France. The pre-conference preceded the Annual Congress of the International Academy ofLaw and Mental Health. Other chapters were solicited after the conference in order to more completely explore the relation of personhood to health care. The pre conference was held in honor of Yves Pelicier who led so many of our French colleagues in medicine, philosophy, and ethics as Christian Herve notes in his Tribute. As health care is aimed at healing persons, it is important to realize how difficult it is to construct a theory of personhood for health care, and thus, a theory of how healing in health care comes about or ought to occur. The book is divided into four parts, Concepts of the Person, Theories of Personhood in Relation to Health Care and Bioethics, Person and Identity, and Personhood and Hs Relations. Each section explores a critical arena in constructing the relation of personhood to health care. Although no exploration ofthis nature can be exhaustive, every effort was made to present both conflicting and complementary views of personhood from within similar and different philosophical and religious traditions. PART ONE: CONCEPTS OF THE PERSON Tracing the origins of the concept of person from antiquity through present day, Jean Delemeau provides an historical sketch of the development of a wide range of meanings."

Medicine and Money: A Study of the Role of Beneficence in Health Care Cost Containment is a frank discussion of the moral problems associated with the need to control health care costs. The book provides a base for physicians to address these concerns and examines the events leading to America's current health care crisis, diminishing beneficence. After a brief definition of the problem, Frank H. Marsh and Mark Yarborough continue by describing the threat of cost containment and justifying beneficence-based health care system. Special importance is given to Medicine and Money by the lengthy suggestions on implementing beneficence in the health care system. Marsh and Yarborough address the problem of eroding morality and rising cost concerns of our present health care system. They argue that if the central role of beneficence is abandoned, the medical profession will be unable to properly meet the challenge it faces. Medicine and Money divides its argument into two sections. In the first section, the current crisis in health care is examined and a justification for beneficence is given. The second section describes how beneficence can be implemented in the health care system as a means to control health care costs. Medicine and Money is written for every member of the medical and philosophical communities.

Synthetic biology is a dynamic, young, ambitious, attractive, and heterogeneous scientific discipline. It is constantly developing and changing, which makes societal evaluation of this emerging new science a challenging task, prone to misunderstandings. Synthetic biology is difficult to capture, and confusion arises not only regarding which part of synthetic biology the discussion is about, but also with respect to the underlying concepts in use. This book offers a useful toolbox to approach this complex and fragmented field. It provides a biological access to the discussion using a 'layer' model that describes the connectivity of synthetic or semisynthetic organisms and cells to the realm of natural organisms derived by evolution.Instead of directly reviewing the field as a whole, firstly our book addresses the characteristic features of synthetic biology that are relevant to the societal discussion. Some of these features apply only to parts of synthetic biology, whereas others are relevant to synthetic biology as a whole. In the next step, these new features are evaluated with respect to the different areas of synthetic biology. Do we have the right words and categories to talk about these new features? In the third step, traditional concepts like "life" and "artificiality" are scrutinized with regard to their discriminatory power. This approach may help to differentiate the discussion on synthetic biology. Lastly our refined view is utilized for societal evaluation. We have investigated the public views and attitudes to synthetic biology. It also includes the analysis of ethical, risk and legal questions, posed by present and future practices of synthetic biology.This book contains the results of an interdisciplinary research project and presents the authors' main findings and recommendations. They are addressed to science, industry, politics and the general public interested in this upcoming field of biotechnology.

The volume aims to capture a European gist of theoretical sensibilities, conceptual resources, and research interests, but not in an adversarial way, as opposed to American bioethics. The volume gathers contributions from European scholars as they collaborate and form a research network, drawing on a diversity of philosophical traditions and local knowledge, with the aim of debating universal bioethical problems. ABSTRACTING & INDEXING Contemporary Debates in Bioethics: European Perspectives is covered by the following services: Baidu Scholar DOAB (Directory of Open Access Books) EBSCO Discovery Service Google Scholar J-Gate Naviga (Softweco) Primo Central (ExLibris) ReadCube Semantic Scholar Summon (ProQuest) TDOne (TDNet) WorldCat (OCLC)

Bioethical and medical issues are among the most important concerns facing society today. Yet many of these contemporary debates have been anticipated and addressed in literary works. Designed to meet the needs of high school students, as well as college students or those in the health care field, this reference defines and situates major bioethical and medical issues in accessible literature ranging from Mary Shelley's Frankenstein (1818) to Margaret Edson's Wit (1999). Included are discussions of such topics as cloning, bioterrorism, organ transplants, genetics, obesity and heart disease, AIDS and sexually transmitted diseases, and civil rights. Chapters are devoted to broad categories, with each chapter discussing two major literary works. Tremendous advances in science and technology have made bioethical and medical issues central to contemporary philosophical debates. Many of these modern concerns have been anticipated and addressed to varying degrees in numerous literary works. Designed to meet the needs of high school students and teachers, pre-med and other college students, as well as any one in or entering a health care profession, this reference, a valuable addition to academic and public libraries, discusses literature as a means of approaching medical and bioethical issues. Chapters look at such broad topics as technology's creature, illness and culture, and end of life issues, with each chapter offering a close examination of two major literary works. Special features include a chronology of events in literature, medicine, and science; a glossary of literary, medical, and scientific terms; and lists of movies, Web sites, books and journals, and teaching methods.

"The 60% Solution should be required reading for political and industry leaders focused on healthcare reform. Timely, insightful and comprehensible." - Eric Affeldt Chairman, Vail Health The 60% Solution offers a bold new vision of how to radically improve the availability and affordability of healthcare by focusing on five critical components: Emphasizing primary care, Clarifying pricing Standardizing accounting and IT Modifying Health Savings Accounts Changing governance #1 Bestselling author Todd Furniss, an industry insider, offers clear and practical solutions to the complexity of healthcare while examining the historical missteps that landed us facing ongoing systemic dysfunction. The book takes on the task of solving the impersonality of healthcare as well as creating an industry that embraces and manifests a compassionate delivery model, putting the power of choice in the center of the relationship of doctor/care-giver and patient. The 60% Solution makes activists out of the 60% of Americans with private healthcare insurance. Our current system is far too costly, ineffectual, and cold; it violates the ideological and moral tenets of a caring nation. High insurance premiums and insurmountably large bills have left countless citizens under mounds of debt or rolling the dice with their lives. This book is about the actionable measures we as individuals can take to become financially capable, educated, and engaged enough to demand the far-reaching reform necessary. It is an inspiring call to action to have all see the benefit of true healthcare reform that focuses on driving consumerism while vastly improving personal choice and access to affordable care.

This book focuses on ethical issues faced by a variety of healthcare practitioners across the Anglophone African continent. This important resource contains in-depth discussions of the most salient current ethical issues by experts in various healthcare fields. Each profession is described from both an African and a South African perspective, and thus contributes to dialogue and critical thinking around African ethics and decision-making. In this way the book provides readers with an understanding of the ethical issues at hand in various professions, including the practical implications of the ethical issues and how to address those effectively. This is a beneficial resource for all those involved in the various healthcare professions addressed in this book, including undergraduate students, lecturers, researchers and practitioners across the continent. Simply put, with the dynamic changes and challenges in healthcare across the globe and in Africa, this is an indispensable resource for healthcare practitioners.

This book provides extensive and critical engagement with some of the most recent and compelling arguments favoring abortion choice. It features original essays from leading and emerging philosophers, bioethicists and medical professionals that present philosophically sophisticated and novel arguments against abortion choice.

"There is hardly a reason to circumcise a little boy for medical reasons because those medical reasons don't exist," said Dr. Michael Wilks, Head of Ethics at the British Medical Association, who admitted that doctors have circumcised boys for "no good reason."

In the United States, parts of Africa, the Middle East, and in the Muslim world, 13.3 million infant boys and 2 million girls have part or all of their external sex organs cut off for reasons that defy logic and violate basic human rights. Doctors, parents, and politicians have been misled into thinking that circumcision is beneficial, necessary, and harmless.

In Circumcision and human rights, internationally respected experts in the fields of medicine, science, politics, law, ethics, sociology, anthropology, history, and religion present the latest research on this tragedy, as a part of the worldwide campaign to end sexual mutilation. They outline steps for eradicating this abusive practice to enable males and females the dignity of living out their lives with all the body parts with which they were born.

Preventive Medicine between Obligation and Aspiration is a study of ethical questions regarding mass screening, vaccination, and health policy programmes. These interventions aim to enhance public health but may also constrain personal autonomy and cause harm, and influence our moral views. So far, these issues have hardly been subject to systematic ethical analysis. This study aims to fill this gap by providing an overview of moral problems in preventive medicine and by explicating norms for good practice. Throughout the book it is argued that some moral concerns about prevention - namely concerns about medicalization - cannot be adequately grasped in terms of strict and binding moral norms. Various moral concepts and types of norms beyond obligation' are explored and developed in order to give practical meaning to these rather vague concerns. In this way the book contributes to applied ethics as well as to ethical theory. It is of interest to professionals in public health and preventive medicine and to scholars in applied ethics and moral philosophy.